Sharon Bio-Medicine Ltd. | Income Statement
Fiscal year is April-March. All values INR Millions.
2011
2012
2013
2014
2016
2017
2018
Sales/Revenue
6,268
8,041
10,735
13,026
3,379
-
-
Cost of Goods Sold (COGS) incl. D&A
5,543
7,068
9,527
11,699
5,089
-
-
Gross Income
725
974
1,208
1,327
1,710
-
-
SG&A Expense
85
101
119
127
273
-
-
EBIT
640
873
1,089
1,200
1,985
-
-
Unusual Expense
-
-
-
222
724
-
-
Non Operating Income/Expense
13
10
10
3
18
-
-
Interest Expense
268
340
431
586
946
-
-
Pretax Income
385
542
670
855
3,629
-
-
Income Tax
53
114
133
151
133
-
-
Consolidated Net Income
332
428
537
703
3,762
-
-
Net Income
332
428
537
703
3,762
-
-
Net Income After Extraordinaries
332
428
537
703
3,762
-
-
Net Income Available to Common
332
428
537
703
3,762
-
-
EPS (Basic)
3.14
4.05
5.09
6.66
31.63
-
-
Basic Shares Outstanding
106
106
106
106
119
-
-
EPS (Diluted)
3.04
3.92
4.92
4.13
31.63
-
-
Diluted Shares Outstanding
109
109
109
170
119
-
-
EBITDA
724
961
1,210
1,354
1,785
-
-
Other Operating Expense
-
-
-
-
2
-
-
Non-Operating Interest Income
-
-
2
17
8
-
-
About Sharon Bio-Medicine
View Profile
